In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...